Cited by 343Nitric Oxide and Endothelin EffectsLipoproteins and Cardiovascular HealthCardiovascular Health and Disease Prevention

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

Open access

Kaesemeyer, Wayne H., Caldwell, Ruth B., Huang, Jianzhong, Caldwell, R.William·1999·Journal of the American College of Cardiology

DOI 10.1016/s0735-1097(98)00514-2

Open this paper in CoChat — free account Open PDF

Abstract

Objectives We tested the hypothesis that pravastatin (PRA) activates endothelial nitric oxide synthase (eNOS).Background Pravastatin has been found to have clinical benefits beyond those predicted by its actions in reducing plasma low density lipoprotein cholesterol (LDL). Both PRA and simvastatin (SIM) are equally effective in reducing LDL, but only PRA reduces platelet aggregation and is an effective vasodilator. Nitric oxide (NO) also inhibits platelet aggregation and vasodilates.Methods We determined PRA and SIM effects on vasorelaxation in aortic rings and NO production by cultured bovine aortic endothelial cells. Nitric oxide was measured by using a NO electrode and by an assay for conversion of hemoglobin to methemoglobin. Specificity of NOS activation was tested by using the NOS inhibitor nitro-L-arginine methyl ester (L-NAME, 1 mmol/liter) in the presence or absence of excess L-arginine (L-ARG, 1 mmol/liter).Results Endothelium-dependent vasorelaxation was maximal with acetylocholine (ACH, 100%), followed by PRA (62.8%) and then SIM (37.1%). Direct measurement of NO confirmed that vasorelaxation is due to NO release and showed that PRA and ACH had similar dose-dependent effects on NO production, while SIM was only 25% to 30% as effective. Methemoglobin assay confirmed these results and demonstrated their specificity for NOS activity. The L-NAME blunted the responses to 45% of initial values. Excess L-ARG reversed this effect and potentiated NO production to 133% of initial levels.Conclusions Both PRA and SIM activate eNOS, but SIM is much less effective. Clinical benefits with PRA not explained by LDL reductions may be the result of an independent action of PRA on eNOS activation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/s0735-1097(98)00514-2

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels
Sacks, F. M., Pfeffer, M. A., Moye, L. A., Rouleau, J. L., Rutherford, J. D., Cole, T. G., Brown, L., Warnica, J. W., Arnold, J. M. O., Wun, C.-C., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610033351401 · Cited by 7,439
Biochemistry of nitric oxide and its redox-activated forms
Stamler, J. S., Singel, D. J., & Loscalzo, J. (1992) · Science · doi:10.1126/science.1281928 · Cited by 2,744
Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release.
Steinberg, H. O., Brechtel, G., Johnson, A., Fineberg, N. S., & Baron, A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117433 · Cited by 1,216
Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM
Tatti, P., Pahor, M., Byington, R. P., Mauro, P. D., Guarisco, R., Strollo, G., & Strollo, F. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.597 · Cited by 843
Influence of Pravastatin and Plasma Lipids on Clinical Events in the West of Scotland Coronary Prevention Study (WOSCOPS)
(1998) · Circulation · doi:10.1161/01.cir.97.15.1440 · Cited by 792
Lipoprotein Changes and Reduction in the Incidence of Major Coronary Heart Disease Events in the Scandinavian Simvastatin Survival Study (4S)
Pedersen, T. R., OLSSON, A. G., Færgeman, O., KJEKSHUS, J. K., Wedel, H., Berg, K., Wilhelmsen, L., Haghfelt, T. H., Þorgeirsson, G., Pyörälà, K., et al. (1998) · Circulation · doi:10.1161/01.cir.97.15.1453 · Cited by 618
17β-Estradiol Attenuates Acetylcholine-Induced Coronary Arterial Constriction in Women but Not Men With Coronary Heart Disease
Collins, P. D., Rosano, G. M. C., Sarrel, P. M., Ulrich, L. G., Adamopoulos, S. N., Beale, C. M., McNeill, J. G., & Poole-Wilson, P. A. (1995) · Circulation · doi:10.1161/01.cir.92.1.24 · Cited by 530
Native Low-Density Lipoprotein Increases Endothelial Cell Nitric Oxide Synthase Generation of Superoxide Anion
Pritchard, K. A., Groszek, L., Smalley, D. M., Sessa, W. C., Wu, M., Villalon, P., Wolin, M. S., & Stemerman, M. B. (1995) · Circulation Research · doi:10.1161/01.res.77.3.510 · Cited by 470
Hydrophilicity/ lipophilicity: relevance for the pharmacology and clinical effects of HMG-CoA reductase inhibitors
Hamelin, B. A. (1998) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01147-4 · Cited by 468
Inhibition of 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase Blocks Hypoxia-mediated Down-regulation of Endothelial Nitric Oxide Synthase
Laufs, U., Fata, V. L., & Liao, J. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31725 · Cited by 384
Relationship Between Plasma LDL Concentrations During Treatment With Pravastatin and Recurrent Coronary Events in the Cholesterol and Recurrent Events Trial
Sacks, F. M., Moyé, L. A., Davis, B. R., Cole, T. G., Rouleau, J. L., Nash, D. T., Pfeffer, M. A., & Braunwald, E. (1998) · Circulation · doi:10.1161/01.cir.97.15.1446 · Cited by 371
Pravastatin Has Cholesterol-Lowering Independent Effects on the Artery Wall of Atherosclerotic Monkeys
Williams, J. K., Sukhova, G. K., Herrington, D. M., & Libby, P. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00537-8 · Cited by 347
Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism.
Cockcroft, J. R., Chowienczyk, P., Brett, S., Chen, C., Dupont, A. G., Nueten, L. V., Wooding, S. J., & Ritter, J. M. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10549-1 · Cited by 324
Reduction in Cardiovascular Events During Pravastatin Therapy
Byington, R. P., Jukema, J. W., Salonen, J. T., Pitt, B., Bruschke, A. V. G., Hoen, H. M., Furberg, C. D., & Mancini, G. B. J. (1995) · Circulation · doi:10.1161/01.cir.92.9.2419 · Cited by 282
Amlodipine Releases Nitric Oxide From Canine Coronary Microvessels
Zhang, X., & Hintze, T. H. (1998) · Circulation · doi:10.1161/01.cir.97.6.576 · Cited by 268
Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production
Böger, R. H., Bode-Böger, S. M., Mügge, A., Kienke, S., Brandes, R., Dwenger, A., & Frölich, J. C. (1995) · Atherosclerosis · doi:10.1016/0021-9150(95)05582-h · Cited by 252
ACE Inhibitors Promote Nitric Oxide Accumulation to Modulate Myocardial Oxygen Consumption
Zhang, X., Xie, Y.-W., Nasjletti, A., Xu, X., Wolin, M. S., & Hintze, T. H. (1997) · Circulation · doi:10.1161/01.cir.95.1.176 · Cited by 181
Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic Humans
Wolf, A., Zalpour, C., Theilmeier, G., Wang, B., Ma, A. O., Anderson, B. E., Tsao, P. S., & Cooke, J. P. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00523-8 · Cited by 171
Biotransformation of organic nitrates to nitric oxide by vascular smooth muscle and endothelial cells
Feelisch, M., & Kelm, M. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)81290-2 · Cited by 162
Effects of Lipid-Lowering Agents in the Dahl Salt-Sensitive Rat
Wilson, T. W., Alonso‐Galicia, M., & Roman, R. J. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.225 · Cited by 108
Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells.
Yokokawa, K., Tahara, H., Kohno, M., Mandal, A. K., Yanagisawa, M., & Takeda, T. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116805 · Cited by 101
Effect of atorvastatin on plasma fibrinogen
Wierzbicki, A. S., Lumb, P. J., Seinra, Y. K., & Crook, M. A. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78556-1 · Cited by 94
Different effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors of sterol synthesis in various human cell types
van Vliet, A. K., van Thiel, G. C. F., Huisman, R. H., Moshage, H. J., Yap, S. H., & Cohen, L. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(94)00176-y · Cited by 87
Direct measurement of nitric oxide release from vascular endothelial cells
Guo, J. P., Murohara, T., Buerke, M., Scalia, R. G., & Lefer, A. M. (1996) · Journal of Applied Physiology · doi:10.1152/jappl.1996.81.2.774 · Cited by 82
Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin
Muramatsu, J. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(96)06024-8 · Cited by 74
Amidative peptide processing and vascular function
Oldham, C. D., Li, C., Feng, J. X., Scott, R. O., Wang, W. Z., Moore, A. B., Girard, P. R., Huang, J., Caldwell, R. B., Caldwell, R. W., et al. (1997) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1997.273.6.c1908 · Cited by 55
Contribution of nitric oxide to the endothelium‐dependent hyperpolarization in rat aorta.
Vanheel, B., de Voorde, J. V., & Leusen, I. R. (1994) · The Journal of Physiology · doi:10.1113/jphysiol.1994.sp020068 · Cited by 49
Modulation of vascular tone by low density lipoproteins: effects on L‐arginine transport and nitric oxide synthesis
Jay, M. T., Chirico, S., Siow, R., Bruckdorfer, K. R., Jacobs, M., Leake, D. S., Pearson, J. D., & Mann, G. E. (1997) · Experimental Physiology · doi:10.1113/expphysiol.1997.sp004030 · Cited by 48
Flow Behavior of Erythrocytes in Microvessels and Glass Capillaries: Effects of Erythrocyte Deformation and Erythrocyte Aggregation
Suzuki, Y., Tateishi, N., SOUTANI, M., & Maeda, N. (2008) · International Journal of Microcirculation · doi:10.1159/000179172 · Cited by 46
Comparative effect of pravastatin and simvastatin on platelet-thrombus formation in hypercholesterolemic coronary patients
Lacoste, L., & Lam, J. Y. T. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)82590-3 · Cited by 38
The effects of nitric oxide (NO) on platelet membrane receptor expression during activation with human ??-thrombin
Keh, D., Gerlach, M., rer, I. K., Seiler, S., Kerner, T., Falke, K. J., & Gerlach, H. (1996) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199609000-00007 · Cited by 37
S-nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats: role of the endothelium.
Delyani, J. A., Nossuli, T. O., Scalia, R. G., Thomas, G., Garvey, D. S., & Lefer, A. M. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21274-5 · Cited by 29
Endothelium-dependent relaxation of rat thoracic aorta by amrinone-induced nitric oxide release
Mori, K. J., Takeuchi, S., Moritoki, H., Tsuchiya, K., Nakaya, Y., Matsuoka, S., & Kuroda, Y. (1996) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a014850 · Cited by 25
Hypertension and Diabetes and the Fosinopril Versus Amlodipine Cardiovascular Events Trial (FACET): More ammunition against surrogate end points
Califf, R. M., & Granger, C. B. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.655 · Cited by 22
Enhancement of Migration Activity in Cholesterol-Poor Endothelial Cells by Pretreating with HMG-CoA Reductase Inhibitors
Ma, L., Morita, I., & Murota, S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2331 · Cited by 12
L-arginine in the development and reversal of tolerance to nitroglycerin
Abou-Mohamed, G. (1996) · American Journal of Hypertension · doi:10.1016/0895-7061(96)81543-3 · Cited by 3
Nitroglycerin (NTG), but not sodium nitroprusside (SNP), increases vascular cGMP levels via an L-arginine dependent and L-NAME sensitive pathway
Abou-Mohamed, G., Kaesemeyer, W., Papapetropoulos, A., Catravas, J. D., & Caldwell, R. W. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)80631-0 · Cited by 2

Research works printed but not linked: 3

Cockcroft, 1995, Nebivolol vasodilates human forearm vasculature, J Pharmacol Exp Ther, 274, 1067
Delanyi, 1996, S-Nitrosylated tissue-type plasminogen activator protects against myocardial ischemia/reperfusion injury in cats, J Pharmacol Exp Ther, 279, 1174
Kaesemeyer, 1997, Nitrates supplemented with l-arginine for the reversal and treatment of nitrate tolerance, Appl Cardiopulmon Pathophys, 6, 255

Sorted by citations

Statins and the risk of dementia
Jick, H., Zornberg, G. L., Jick, S. S., Seshadri, S. S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,764
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals.
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D. J., Lefer, D. J., Sessa, W. C., & Walsh, K. X. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,438
Drug Treatment of Lipid Disorders
Knopp, R. H. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410707 · Cited by 844
New insights into the pharmacodynamic and pharmacokinetic properties of statins
Corsini, A., Bellosta, S., Baetta, R., Fumagalli, R., Paoletti, R., & Bernini, F. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00045-5 · Cited by 796
Statin effects beyond lipid lowering—are they clinically relevant?
Bonetti, P. O. (2003) · European Heart Journal · doi:10.1016/s0195-668x(02)00419-0 · Cited by 526
“80 Importantly, this effect was associated with an upregulation of vascular eNOS protein levels and a consecutive increase in NO bioavailability, indicating again an antiinflammatory role for NO.”
Influential

See all 343

Authors: Kaesemeyer, W. H., Caldwell, R. B., Huang, J., & Caldwell, R. W.
Affiliations: Augusta University (US)
Corresponding author: Kaesemeyer, Wayne H.
ORCID: Kaesemeyer, Wayne H.
Caldwell, Ruth B.
Huang, Jianzhong
Caldwell, R.William
Venue: Journal of the American College of Cardiology
Publisher: Elsevier BV
Published: 1999-01
Volume: 33
Issue: 1
Pages: 234-241
ISSN: 0735-1097 (ISSN-L)
DOI: 10.1016/s0735-1097(98)00514-2
OpenAlex: W2169537677
Cited by: 343
References: 38
Citations by year: 2026: 1 · 2025: 1 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 4 · 2018: 6 · 2017: 8 · 2016: 8 · 2015: 7 · 2014: 8 · 2013: 10 · 2012: 9
FWCI: 19.26
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 5310 d)
Locations: Journal of the American College of Cardiology (publishedVersion)
PubMed (publishedVersion)
Funders: Bristol-Myers Squibb
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
Keywords: pravastatin, simvastatin, endothelial nitric oxide synthase, nitric oxide, endothelium-dependent relaxation, platelet aggregation, vasodilation, L-NAME, L-arginine, statins, LDL cholesterol lowering, aortic endothelial cells
MeSH terms: Animals, Anticholesteremic Agents, Cattle, Endothelium, Vascular, Enzyme Activation, Cholesterol, LDL, Male, Platelet Aggregation, Vasodilation, Pravastatin, Rats, Sprague-Dawley, Nitric Oxide Synthase, Culture Techniques, Rats, Nitric Oxide Synthase Type III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks